BOFFA, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 3.878
NA - Nord America 752
AS - Asia 745
Continente sconosciuto - Info sul continente non disponibili 151
SA - Sud America 63
AF - Africa 7
OC - Oceania 2
Totale 5.598
Nazione #
IT - Italia 3.786
US - Stati Uniti d'America 694
SG - Singapore 283
CN - Cina 186
VN - Vietnam 137
BD - Bangladesh 63
BR - Brasile 34
FR - Francia 28
HK - Hong Kong 25
CA - Canada 24
DE - Germania 14
IN - India 12
GB - Regno Unito 11
AR - Argentina 10
MX - Messico 9
JP - Giappone 8
NL - Olanda 7
FI - Finlandia 6
RU - Federazione Russa 6
CO - Colombia 5
EC - Ecuador 5
ID - Indonesia 5
PK - Pakistan 5
TT - Trinidad e Tobago 5
JM - Giamaica 4
NI - Nicaragua 4
AZ - Azerbaigian 3
CH - Svizzera 3
GT - Guatemala 3
PH - Filippine 3
TW - Taiwan 3
VE - Venezuela 3
CL - Cile 2
HN - Honduras 2
IE - Irlanda 2
IQ - Iraq 2
MA - Marocco 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
TH - Thailandia 2
UA - Ucraina 2
ZA - Sudafrica 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SE - Svezia 1
TN - Tunisia 1
Totale 5.448
Città #
Genoa 1.943
Genova 904
Vado Ligure 494
Rapallo 332
San Jose 165
Ashburn 147
Singapore 133
Ho Chi Minh City 54
Beijing 51
New York 38
Hong Kong 25
Lauterbourg 25
Hanoi 22
Los Angeles 21
Council Bluffs 20
Rome 15
Milan 13
Santa Clara 13
Buffalo 12
Boardman 10
Chicago 10
Frankfurt am Main 10
Montreal 9
Naples 9
Bologna 7
Haiphong 7
Da Nang 6
Helsinki 6
Tokyo 6
Biên Hòa 5
Dallas 5
Houston 5
Mexico City 5
Toronto 5
Bordighera 4
Managua 4
Ninh Bình 4
Philadelphia 4
Turin 4
Brooklyn 3
Guatemala City 3
Kingston 3
London 3
Paris 3
Phoenix 3
São Paulo 3
Tampa 3
Thái Nguyên 3
Amsterdam 2
Atlanta 2
Aurora 2
Baku 2
Barrie 2
Belgrade 2
Boston 2
Brasília 2
Bình Phước 2
Calenzano 2
Can Tho 2
Catania 2
Chaguanas 2
Changsha 2
Charlotte 2
Citrus Heights 2
City of London 2
Corryton 2
Detroit 2
Fall River 2
Federal Way 2
Florence 2
Grottaminarda 2
Huddersfield 2
Jacksonville 2
Johannesburg 2
Kazan' 2
La Plata 2
Lake Forest 2
Las Vegas 2
Litchfield Park 2
Lyndhurst 2
Newark 2
Norfolk 2
Orem 2
Parma 2
Portland 2
Porto Alegre 2
Quito 2
Quảng Ngãi 2
Richmond 2
Rio de Janeiro 2
Riyadh 2
Rudolfstetten 2
Salem 2
San Antonio 2
San Salvador 2
Santiago 2
Santiago de Cali 2
Spokane 2
Springfield 2
Trenton 2
Totale 4.683
Nome #
Different MRI patterns in MS worsening after stopping fingolimod 207
A two alternative forced choice method for assessing vibrotactile discrimination thresholds in the lower limb 196
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 189
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 186
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 169
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis 162
Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of “black holes” 162
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 156
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 154
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 147
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 147
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab 141
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 141
Impact of highly active immunotherapy on acute and chronic neuroinflammation in aggressive multiple sclerosis 138
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 132
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 128
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 126
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesions 125
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 124
Clinical and radiological correlates of apathy in multiple sclerosis 120
An aggressive form of MOGAD treated with aHSCT: A case report 116
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 115
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases 113
Long-term clinical outcomes of hematopoietic stem cell transplantation in multiple sclerosis 113
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 112
Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis 104
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis 101
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 99
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 98
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 98
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 97
The effect of Cladribine and Fingolimod treatments on retinal atrophy 95
What happens after fingolimod discontinuation? A multicentre real-life experience 94
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis 92
Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis 91
Positron Emission Tomography with [18F]-DPA-714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression 89
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation 83
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 78
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis 77
HSCT for stiff person syndrome and myasthenia gravis 73
A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injury 72
Multiparametric Characterization and Spatial Distribution of Different MS Lesion Phenotypes 67
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 64
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 61
Fronto-temporal vulnerability to disconnection in paediatric moderate and severe traumatic brain injury 56
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience 54
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimod 50
Assessing Optic Nerve Involvement in Multiple SclerosisUsing Optical Coherence Tomography and Magnetic Resonance Imaging 45
Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice 41
Black and Non-Hispanic White persons with multiple sclerosis: Social determinants of health and health inequities 34
null 20
E200k familial creutzfeldt-jakob disease presenting with subacute multiple cranial neuropathy 15
Markerless Video-Based Gait Analysis in People With Multiple Sclerosis 10
Video-based 2D markerless gait analysis in people with multiple sclerosis 6
Unmasking the invisible: Correlates and impact of cognitive complaints in MS 6
The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES+ Tr1-Like Cells 5
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation 4
Totale 5.598
Categoria #
all - tutte 21.580
article - articoli 20.969
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 204
Totale 42.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022250 13 4 7 19 8 21 3 59 22 39 12 43
2022/2023407 31 36 5 48 36 55 2 25 54 20 77 18
2023/2024513 20 34 11 53 33 91 120 20 20 23 29 59
2024/20251.268 82 95 58 73 149 118 95 223 81 63 127 104
2025/20262.263 284 64 159 163 291 110 286 124 198 208 183 193
2026/2027182 182 0 0 0 0 0 0 0 0 0 0 0
Totale 5.598